Flu-like symptoms (fatigue, fever, ... Cite this: Treatment of Cutaneous T-Cell Lymphoma/Mycosis Fungoides - Medscape - Dec 01, 2006. Abstract and Introduction; Background; Therapy; ...

Cite this: Treatment of Cutaneous T-Cell Lymphoma/Mycosis Fungoides - Medscape - Dec 01, 2006. Abstract and Introduction; Background; Therapy; Topical Corticosteroids; Bexarotene Gel; ...

Genmab A/S (Nasdaq: GMAB) today announced new results from the Phase 1b/2 EPCORE® NHL-2 trial Arm 10 (NCT04663347), evaluating epcoritamab, a T-cell engaging ...

"We're really excited to share the first results for our dual-targeting anti-CD19/CD20 CAR T-cell therapy in relapsed or refractory large B-cell lymphoma, underscoring our more than decade-long ...

Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis. JAMA Dermatol . 2016;152(4):419-428. doi:10.1001 ...

A combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic leukaemia (B-ALL), the commonest cancer in childhood and one that can be ...

Symptoms and stages of cutaneous T-cell lymphoma. The symptoms of cutaneous T-cell lymphoma depend on how far the cancer has spread (stage). The symptoms can look like other skin conditions. Make sure ...

Introduction. Mantle Cell Lymphoma (MCL) is a B-cell neoplasm - characterized by clinical and morphological variants - that accounts for about 6% of all Non-Hodgkin Lymphoma (NHL) in the United States ...

Kite Pharma’s bicistronic CAR T-cell therapy hit the main goal of a phase 1a trial, with zero dose-limiting toxicities (DLTs) occurring in patients with advanced B-cell lymphoma (BCL).

Diffuse large B-cell lymphoma (DLBCL) Diffuse large B-cell lymphoma (DLBCL) is the most common type of NHL in the United States, accounting for about 1 out of every 3 lymphomas. The lymphoma cells ...